The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Eluting Balloon for Coronary Artery Disease Market Research Report 2025
Synopsis
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
The global Drug Eluting Balloon for Coronary Artery Disease market was valued at US$ 441.3 million in 2023 and is anticipated to reach US$ 1229.4 million by 2030, witnessing a CAGR of 15.8% during the forecast period 2024-2030.
The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloon for Coronary Artery Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloon for Coronary Artery Disease.
Report Scope
The Drug Eluting Balloon for Coronary Artery Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Balloon for Coronary Artery Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloon for Coronary Artery Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Yinyi
Eurocor
Biotronic
Segment by Type
Paclitaxel Coated
Other Coated
Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloon for Coronary Artery Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloon for Coronary Artery Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
The global Drug Eluting Balloon for Coronary Artery Disease market was valued at US$ 441.3 million in 2023 and is anticipated to reach US$ 1229.4 million by 2030, witnessing a CAGR of 15.8% during the forecast period 2024-2030.
The Coronary Drug-Coated Balloon market is driven by the need for improved treatment options for coronary artery disease (CAD). These specialized balloons are designed to deliver drugs directly to the site of arterial blockages during angioplasty, preventing restenosis and promoting vessel healing. The rise in CAD cases and the demand for minimally invasive interventions contribute to market growth as patients and cardiologists seek solutions that reduce the need for repeat procedures. Moreover, advancements in drug formulation and balloon technology, including controlled drug release and enhanced drug adherence, align with better patient outcomes. However, the market also faces challenges, including addressing the potential for adverse reactions to the drug coating and ensuring precise drug delivery to the targeted area. Additionally, navigating regulatory approvals and conducting long-term efficacy studies can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and effective drug-coated balloon solutions, collaborate with interventional cardiologists for insights, and address the challenges to meet the increasing demand for advanced CAD treatment options.
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Balloon for Coronary Artery Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Balloon for Coronary Artery Disease.
Report Scope
The Drug Eluting Balloon for Coronary Artery Disease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Eluting Balloon for Coronary Artery Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Balloon for Coronary Artery Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun
Yinyi
Eurocor
Biotronic
Segment by Type
Paclitaxel Coated
Other Coated
Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Balloon for Coronary Artery Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Balloon for Coronary Artery Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Drug Eluting Balloon for Coronary Artery Disease Market Overview
1.1 Product Overview and Scope of Drug Eluting Balloon for Coronary Artery Disease
1.2 Drug Eluting Balloon for Coronary Artery Disease Segment by Type
1.2.1 Global Drug Eluting Balloon for Coronary Artery Disease Market Value Comparison by Type (2024-2030)
1.2.2 Paclitaxel Coated
1.2.3 Other Coated
1.3 Drug Eluting Balloon for Coronary Artery Disease Segment by Application
1.3.1 Global Drug Eluting Balloon for Coronary Artery Disease Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Global Drug Eluting Balloon for Coronary Artery Disease Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Balloon for Coronary Artery Disease Revenue 2019-2030
1.4.2 Global Drug Eluting Balloon for Coronary Artery Disease Sales 2019-2030
1.4.3 Global Drug Eluting Balloon for Coronary Artery Disease Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Drug Eluting Balloon for Coronary Artery Disease Market Competition by Manufacturers
2.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Manufacturers (2019-2024)
2.2 Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Drug Eluting Balloon for Coronary Artery Disease Average Price by Manufacturers (2019-2024)
2.4 Global Drug Eluting Balloon for Coronary Artery Disease Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Drug Eluting Balloon for Coronary Artery Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Drug Eluting Balloon for Coronary Artery Disease, Product Type & Application
2.7 Drug Eluting Balloon for Coronary Artery Disease Market Competitive Situation and Trends
2.7.1 Drug Eluting Balloon for Coronary Artery Disease Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Drug Eluting Balloon for Coronary Artery Disease Players Market Share by Revenue
2.7.3 Global Drug Eluting Balloon for Coronary Artery Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Balloon for Coronary Artery Disease Retrospective Market Scenario by Region
3.1 Global Drug Eluting Balloon for Coronary Artery Disease Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Drug Eluting Balloon for Coronary Artery Disease Global Drug Eluting Balloon for Coronary Artery Disease Sales by Region: 2019-2030
3.2.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Region: 2019-2024
3.2.2 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Region: 2025-2030
3.3 Global Drug Eluting Balloon for Coronary Artery Disease Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Region: 2019-2030
3.3.1 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Region: 2019-2024
3.3.2 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Region: 2025-2030
3.4 North America Drug Eluting Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.4.1 North America Drug Eluting Balloon for Coronary Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2030)
3.4.3 North America Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Balloon for Coronary Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2030)
3.5.3 Europe Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.6.1 Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2030)
3.6.3 Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Balloon for Coronary Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2030)
3.7.3 Latin America Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Balloon for Coronary Artery Disease Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Balloon for Coronary Artery Disease Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2030)
3.8.3 Middle East and Africa Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Type (2019-2030)
4.1.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Type (2019-2024)
4.1.2 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Type (2025-2030)
4.1.3 Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Type (2019-2030)
4.2 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Type (2019-2030)
4.2.1 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Type (2019-2024)
4.2.2 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Type (2025-2030)
4.2.3 Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Type (2019-2030)
4.3 Global Drug Eluting Balloon for Coronary Artery Disease Price by Type (2019-2030)
5 Segment by Application
5.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Application (2019-2030)
5.1.1 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Application (2019-2024)
5.1.2 Global Drug Eluting Balloon for Coronary Artery Disease Sales by Application (2025-2030)
5.1.3 Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Application (2019-2030)
5.2 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Application (2019-2030)
5.2.1 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Application (2019-2024)
5.2.2 Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Application (2025-2030)
5.2.3 Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Application (2019-2030)
5.3 Global Drug Eluting Balloon for Coronary Artery Disease Price by Application (2019-2030)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Drug Eluting Balloon for Coronary Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.1.4 B. Braun Drug Eluting Balloon for Coronary Artery Disease Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Yinyi
6.2.1 Yinyi Corporation Information
6.2.2 Yinyi Description and Business Overview
6.2.3 Yinyi Drug Eluting Balloon for Coronary Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Yinyi Drug Eluting Balloon for Coronary Artery Disease Product Portfolio
6.2.5 Yinyi Recent Developments/Updates
6.3 Eurocor
6.3.1 Eurocor Corporation Information
6.3.2 Eurocor Description and Business Overview
6.3.3 Eurocor Drug Eluting Balloon for Coronary Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eurocor Drug Eluting Balloon for Coronary Artery Disease Product Portfolio
6.3.5 Eurocor Recent Developments/Updates
6.4 Biotronic
6.4.1 Biotronic Corporation Information
6.4.2 Biotronic Description and Business Overview
6.4.3 Biotronic Drug Eluting Balloon for Coronary Artery Disease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biotronic Drug Eluting Balloon for Coronary Artery Disease Product Portfolio
6.4.5 Biotronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Balloon for Coronary Artery Disease Industry Chain Analysis
7.2 Drug Eluting Balloon for Coronary Artery Disease Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Balloon for Coronary Artery Disease Production Mode & Process
7.4 Drug Eluting Balloon for Coronary Artery Disease Sales and Marketing
7.4.1 Drug Eluting Balloon for Coronary Artery Disease Sales Channels
7.4.2 Drug Eluting Balloon for Coronary Artery Disease Distributors
7.5 Drug Eluting Balloon for Coronary Artery Disease Customers
8 Drug Eluting Balloon for Coronary Artery Disease Market Dynamics
8.1 Drug Eluting Balloon for Coronary Artery Disease Industry Trends
8.2 Drug Eluting Balloon for Coronary Artery Disease Market Drivers
8.3 Drug Eluting Balloon for Coronary Artery Disease Market Challenges
8.4 Drug Eluting Balloon for Coronary Artery Disease Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Drug Eluting Balloon for Coronary Artery Disease Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Drug Eluting Balloon for Coronary Artery Disease Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Drug Eluting Balloon for Coronary Artery Disease Market Competitive Situation by Manufacturers in 2023
Table 4. Global Drug Eluting Balloon for Coronary Artery Disease Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Drug Eluting Balloon for Coronary Artery Disease Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Drug Eluting Balloon for Coronary Artery Disease, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Drug Eluting Balloon for Coronary Artery Disease, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Drug Eluting Balloon for Coronary Artery Disease, Product Type & Application
Table 12. Global Key Manufacturers of Drug Eluting Balloon for Coronary Artery Disease, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Drug Eluting Balloon for Coronary Artery Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Eluting Balloon for Coronary Artery Disease as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Drug Eluting Balloon for Coronary Artery Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Drug Eluting Balloon for Coronary Artery Disease Sales by Region (2019-2024) & (K Units)
Table 18. Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Region (2019-2024)
Table 19. Global Drug Eluting Balloon for Coronary Artery Disease Sales by Region (2025-2030) & (K Units)
Table 20. Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Region (2025-2030)
Table 21. Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Region (2019-2024)
Table 23. Global Drug Eluting Balloon for Coronary Artery Disease Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Region (2025-2030)
Table 25. North America Drug Eluting Balloon for Coronary Artery Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2024) & (K Units)
Table 27. North America Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2025-2030) & (K Units)
Table 28. North America Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Drug Eluting Balloon for Coronary Artery Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2024) & (K Units)
Table 32. Europe Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2025-2030) & (K Units)
Table 33. Europe Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Eluting Balloon for Coronary Artery Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Drug Eluting Balloon for Coronary Artery Disease Sales (K Units) by Type (2019-2024)
Table 51. Global Drug Eluting Balloon for Coronary Artery Disease Sales (K Units) by Type (2025-2030)
Table 52. Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Type (2019-2024)
Table 53. Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Type (2025-2030)
Table 54. Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Type (2019-2024)
Table 57. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Type (2025-2030)
Table 58. Global Drug Eluting Balloon for Coronary Artery Disease Price (US$/Unit) by Type (2019-2024)
Table 59. Global Drug Eluting Balloon for Coronary Artery Disease Price (US$/Unit) by Type (2025-2030)
Table 60. Global Drug Eluting Balloon for Coronary Artery Disease Sales (K Units) by Application (2019-2024)
Table 61. Global Drug Eluting Balloon for Coronary Artery Disease Sales (K Units) by Application (2025-2030)
Table 62. Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Application (2019-2024)
Table 63. Global Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Application (2025-2030)
Table 64. Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Drug Eluting Balloon for Coronary Artery Disease Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Application (2019-2024)
Table 67. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Application (2025-2030)
Table 68. Global Drug Eluting Balloon for Coronary Artery Disease Price (US$/Unit) by Application (2019-2024)
Table 69. Global Drug Eluting Balloon for Coronary Artery Disease Price (US$/Unit) by Application (2025-2030)
Table 70. B. Braun Corporation Information
Table 71. B. Braun Description and Business Overview
Table 72. B. Braun Drug Eluting Balloon for Coronary Artery Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. B. Braun Drug Eluting Balloon for Coronary Artery Disease Product
Table 74. B. Braun Recent Developments/Updates
Table 75. Yinyi Corporation Information
Table 76. Yinyi Description and Business Overview
Table 77. Yinyi Drug Eluting Balloon for Coronary Artery Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Yinyi Drug Eluting Balloon for Coronary Artery Disease Product
Table 79. Yinyi Recent Developments/Updates
Table 80. Eurocor Corporation Information
Table 81. Eurocor Description and Business Overview
Table 82. Eurocor Drug Eluting Balloon for Coronary Artery Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eurocor Drug Eluting Balloon for Coronary Artery Disease Product
Table 84. Eurocor Recent Developments/Updates
Table 85. Biotronic Corporation Information
Table 86. Biotronic Description and Business Overview
Table 87. Biotronic Drug Eluting Balloon for Coronary Artery Disease Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Biotronic Drug Eluting Balloon for Coronary Artery Disease Product
Table 89. Biotronic Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Drug Eluting Balloon for Coronary Artery Disease Distributors List
Table 93. Drug Eluting Balloon for Coronary Artery Disease Customers List
Table 94. Drug Eluting Balloon for Coronary Artery Disease Market Trends
Table 95. Drug Eluting Balloon for Coronary Artery Disease Market Drivers
Table 96. Drug Eluting Balloon for Coronary Artery Disease Market Challenges
Table 97. Drug Eluting Balloon for Coronary Artery Disease Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Eluting Balloon for Coronary Artery Disease
Figure 2. Global Drug Eluting Balloon for Coronary Artery Disease Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drug Eluting Balloon for Coronary Artery Disease Market Share by Type in 2023 & 2030
Figure 4. Paclitaxel Coated Product Picture
Figure 5. Other Coated Product Picture
Figure 6. Global Drug Eluting Balloon for Coronary Artery Disease Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Drug Eluting Balloon for Coronary Artery Disease Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. ASCs
Figure 10. Catheterization Laboratory
Figure 11. Global Drug Eluting Balloon for Coronary Artery Disease Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Drug Eluting Balloon for Coronary Artery Disease Market Size (2019-2030) & (US$ Million)
Figure 13. Global Drug Eluting Balloon for Coronary Artery Disease Sales (2019-2030) & (K Units)
Figure 14. Global Drug Eluting Balloon for Coronary Artery Disease Average Price (US$/Unit) & (2019-2030)
Figure 15. Drug Eluting Balloon for Coronary Artery Disease Report Years Considered
Figure 16. Drug Eluting Balloon for Coronary Artery Disease Sales Share by Manufacturers in 2023
Figure 17. Global Drug Eluting Balloon for Coronary Artery Disease Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Drug Eluting Balloon for Coronary Artery Disease Players: Market Share by Revenue in 2023
Figure 19. Drug Eluting Balloon for Coronary Artery Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Drug Eluting Balloon for Coronary Artery Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Country (2019-2030)
Figure 22. North America Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Country (2019-2030)
Figure 23. United States Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Country (2019-2030)
Figure 26. Europe Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Country (2019-2030)
Figure 27. Germany Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Region (2019-2030)
Figure 34. China Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Country (2019-2030)
Figure 44. Latin America Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Drug Eluting Balloon for Coronary Artery Disease Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Drug Eluting Balloon for Coronary Artery Disease Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Drug Eluting Balloon for Coronary Artery Disease by Type (2019-2030)
Figure 54. Global Revenue Market Share of Drug Eluting Balloon for Coronary Artery Disease by Type (2019-2030)
Figure 55. Global Drug Eluting Balloon for Coronary Artery Disease Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Drug Eluting Balloon for Coronary Artery Disease by Application (2019-2030)
Figure 57. Global Revenue Market Share of Drug Eluting Balloon for Coronary Artery Disease by Application (2019-2030)
Figure 58. Global Drug Eluting Balloon for Coronary Artery Disease Price (US$/Unit) by Application (2019-2030)
Figure 59. Drug Eluting Balloon for Coronary Artery Disease Value Chain
Figure 60. Drug Eluting Balloon for Coronary Artery Disease Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
